已收盤 11-08 16:00:00 美东时间
0.000
0.00%
Arvinas (NASDAQ:ARVN) on Monday announced the appointment of Andrew Saik to the role of Chief Financial Officer and Treasurer. Saik, most recently, served as CFO at Intercept Pharmaceuticals. Prior to...
06-25 04:41
·Rezdiffra是40年来首款获FDA批准上市的MASH药物。过去十年,MASH一直是药物研发热点,但由于发病机制复杂,进展寥寥。辉瑞、百时美施贵宝、吉利德...
03-18 08:34
Awards Mr. Freedberg an Inducement Grant in accordance with Nasdaq Listing Rule...
01-17 06:01
全球领先的先进锂离子电池制造商LG能源解决方案(LG Energy Solution)和全球领先的公共交通重型电池系统供应商Impact Clean Powe...
2023-12-08 14:48
Matthew Cullen Joins as Vice President of Value and Access Lisa DeFrancesco Joi...
2023-11-01 04:01
越来越多的明星biotech,选择“退出”创新药市场。 Mirati是最新的卖身者。然而,与大部分biotech由于弹尽粮绝、身处险境而寻求卖身不同,Mira...
2023-10-10 08:04
NEW YORK, Oct. 4, 2023 /PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims con...
2023-10-05 01:52
Over the past 3 months, 5 analysts have published their opinion on Intercept Ph...
2023-09-27 21:01
Immunovant正在开发抗体药物IMVT-1402,小摩表示,若该药物在后续研究中取得成功,或将为同类药物中最好的;Intercept制药隔夜上涨超79%,同意以每股19美元的价格被收购>>
2023-09-27 15:11
What is the target price for Intercept Pharma (ICPT)? The latest price targe...
2023-09-27 11:22